BG
NEO icon

BlackRock Group’s NeoGenomics NEO Stock Holding History

BlackRock Group’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$382K Buy
44,534
+22,748
+104% +$195K ﹤0.01% 2440
2016
Q3 		$179K Buy
21,786
+10,264
+89% +$86.1K ﹤0.01% 2665
2016
Q2 		$93K Buy
+11,522
New +$92.4K ﹤0.01% 2808

Other funds holding NEO

GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Group's NEO Position: Q4 2016 in Review

BlackRock Group increased its NeoGenomics (NEO) stake by 104% in Q4 2016, buying an estimated $195K and bringing the position to 44,534 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #2440.

BlackRock Group first reported a position in NEO in Q2 2016 and has held it in 3 quarters since. 143 funds tracked by Wall St. Rank hold NEO as of Q4 2016.

  • BlackRock Group held 44,534 shares of NeoGenomics worth $382K as of Q4 2016.
  • BlackRock Group bought 22,748 NeoGenomics shares in Q4 2016, an estimated $195K.
  • NeoGenomics made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2440 holding.
  • BlackRock Group first reported a position in NeoGenomics in Q2 2016 and has held it in 3 quarters since.
  • 143 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.